Antipsychotic effects on prepulse inhibition in normal 'low gating' humans and rats

Neuropsychopharmacology

Volumn 31, Issue 9, 2006, Pages 2011-2021

  Swerdlow, Neal R ^a   Talledo, Jo ^a   Sutherland, Ashley N ^a   Nagy, Derek ^a   Shoemaker, Jody M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Clozapine; Prepulse inhibition; Quetiapine; Schizophrenia; Sensorimotor gating; Strain

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; QUETIAPINE;

ADULT; ANIMAL EXPERIMENT; ARTICLE; CHANNEL GATING; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; DRUG RESPONSE; DRUG SENSITIVITY; GENETICS; HIGH RISK POPULATION; HUMAN; MALE; NEUROCHEMISTRY; NONHUMAN; NORMAL HUMAN; PHENOTYPE; PREPULSE INHIBITION; PRIORITY JOURNAL; RAT; RAT STRAIN; SCHIZOPHRENIA; SENSORIMOTOR FUNCTION; STARTLE REFLEX;

ACOUSTIC STIMULATION; ADOLESCENT; ADULT; ANIMALS; ANTIPSYCHOTIC AGENTS; AUTONOMIC NERVOUS SYSTEM; CROSS-OVER STUDIES; DIBENZOTHIAZEPINES; HUMANS; MALE; PHENOTYPE; RATS; RATS, SPRAGUE-DAWLEY; SLEEP STAGES; STARTLE REACTION;

EID: 33747339460     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301043     Document Type: Article

References (42)

1. Abduljawad KA, Langley RW, Bradshaw CM, Szabadi E (1998). Effects of bromocriptine and haloperidol on prepulse inhibition of the acoustic startle response in man. J Psychopharmacol 12: 239-245.
2. Becker K, Laucht M, El-Faddagh M, Schmidt MH (2005). The dopamine D4 receptor gene exon III polymorphism is associated with novelty seeking in 15-year-old males from a high-risk community sample. J Neural Transm 112: 847-858.
3. Bitsios P, Giakoumaki SG, Frangou S (2005). The effects of dopamine agonists on prepulse inhibition in healthy men depend on baseline PPI values. Psychopharmacology 182: 144-152.
4. Bohmelt AH, Schell AM, Dawson ME (1999). Attentional modulation of short- and long-lead-interval modification of the acoustic startle eyeblink response: comparing auditory and visual prestimuli. Int J Psychophysiol 32: 239-250.
5. Braff D, Stone C, Callaway E, Geyer M, Glick I, Bali L (1978). Prestimulus effects on human startle reflex in normals and schizophrenics. Psychophysiology 15: 339-343.
6. Braff DL, Geyer MA, Swerdlow NR (2001). Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology 156: 234-258.
7. Cadenhead KS, Swerdlow NR, Shafer KM, Diaz M, Braff DL (2000). Modulation of the startle response and startle laterality in relatives of schizophrenia patients and schizotypal personality disordered subjects: evidence of inhibitory deficits. Am J Psychiatry 157: 1660-1668.
8. Castellanos FX, Fine EJ, Kaysen DL, Marsh WL, Rapoport JL, Hallett M (1996). Sensorimotor gating in boys with Tourette's syndrome and ADHD: preliminary results. Biol Psychiatry 39: 33-41.
9. Cloninger CR (1987). A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 44: 573-588.
10. Cohen J (1988). Statistical Power Analysis for the Behavioral Sciences. Lawrence Erlbaum: Hillsdale, NJ.
11. Conti LH, Costill JE, Flynn S, Taylor JE (2005). Effects of a typical and an atypical antipychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain. Behav Neurosci 119: 1052-1060.
12. Filion DL, Dawson ME, Schell AM (1993). Modification of the acoustic startle-reflex eyeblink: a tool for investigating early and late attentional processes. Biol Psychol 35: 185-200.
13. First MB, Spitzer RL, Gibbon M, Williams JBW (1997). Structured Clinical Interview for DSM-IV Axis I Disorders, Research Version, Non-patient Edition (SCID-I/NP). Biometrics Research, New York State Psychiatric Institute: New York.
14. Geyer MA, Krebs-Thomson K, Braff DL, Swerdlow NR (2001). Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 156: 117-154.
15. Gomez-Wong E, Marti MJ, Tolosa E, Valls-Sole J (1998). Sensory modulation of the blink reflex in patients with blepharospasm. Arch Neurol 55: 1233-1237.
16. Graham F (1975). The more or less startling effects of weak prestimuli. Psychophysiology 12: 238-248.
17. Graham SJ, Scaife JC, Balboa Verduzco AM, Langley RW, Bradshaw CM, Szabadi E (2004). Effects of quetiapine and haloperidol on prepulse inhibition of the acoustic startle (eyeblink) response and N1/P2 auditory evoked response in man. J Psychopharm 18: 173-180.
18. Hince DA, Martin-Iverson MT (2005). Differences in prepulse inhibition (PPI) between Wistar and Sprague-Dawley rats clarified by a new method of PPI standardization. Behav Neurosci 119: 66-77.
19. Idanpaan-Heikkila J, Alhava E, Olkinuora M, Palva I (1975). Letter: Clozapine and agranulocytosis. Lancet 2: 611.
20. Kumari V, Mulligan OF, Cotter PA, Poon L, Toone BK, Checkley SA et al (1998). Effects of single oral administrations of haloperidol and d-amphetamine on prepulse inhibition of the acoustic startle reflex in healthy male volunteers. Behav Pharmacol 9: 567-576.
21. Kumari V, Soni W, Sharma T (1999). Normalization of information processing deficits in schizophrenia with clozapine. Am J Psychiatry 156: 1046-1051.
22. Oranje B, Kahn RS, Kemner C, Verbaten MN (2004). Modulating sensorimotor gating in healthy volunteers: the effects of desipramine and haloperidol. Psychiatric Res 127: 195-205.
23. Palmer AA, Dulawa SC, Mottiwala AA, Conti LH, Geyer MA, Printz MP (2000). Prepulse startle deficit in the Brown Norway rat: a potential genetic model. Behav Neurosci 114: 374-388.
24. Swerdlow NR, Bakshi V, Geyer MA (1996). Seroquel restores sensorimotor gating in phencyclidine treated rats. J Pharmacol Exp Ther 279: 1290-1299.
25. Swerdlow NR, Benbow CH, Zisook S, Geyer MA, Braff DL (1993). A preliminary assessment of sensorimotor gating in patients with obsessive compulsive disorder. Biol Psychiatry 33: 298-301.
26. Swerdlow NR, Braff DL, Geyer MA (2000). Animal models of deficient sensorimotor gating: what we know, what we think we know, and what we hope to know soon. Behav Pharmacol 111: 185-204.
27. Swerdlow NR, Braff DL, Taaid N, Geyer MA (1994a). Assessing the validity of an animal model of sensorimotor gating deficits in schizophrenic patients. Arch Gen Psychiatry 51: 139-154.
28. Swerdlow NR, Eastvold A, Karban B, Ploum Y, Stephany N, Geyer MA et al (2002a). Dopamine agonist effects on startle and sensorimotor gating in normal control subjects: time course studies. Psychopharmacology 161: 189-201.
29. Swerdlow NR, Eastvold A, Uyan KM, Ploum Y, Cadenhead K (2001a). Matching strategies for drug studies of prepulse inhibition in humans. Behav Pharmacol 12: 45-52.
30. Swerdlow NR, Filion D, Geyer MA, Braff DL (1995a). 'Normal' personality correlates of sensorimotor, cognitive and visuospatial gating. Biol Psychiatry 37: 286-299.
31. Swerdlow NR, Geyer MA (1993). Clozapine and haloperidol in an animal model of sensorimotor gating deficits in schizophrenia. Pharmacol Biochem Behav 44: 741-744.
32. Swerdlow NR, Paulsen J, Braff DL, Butters N, Geyer MA, Swenson MR (1995b). Impaired prepulse inhibition of acoustic and tactile startle in patients with Huntington's disease. J Neurol Neurosurg Psychiatry 58: 192-200.
33. Swerdlow NR, Platten A, Shoemaker J, Pitcher L, Auerbach P (2001b). Effects of pergolide on sensorimotor gating of the startle reflex in rats. Psychopharmacology 158: 230-240.
34. Swerdlow NR, Shoemaker JM, Auerbach PP, Pitcher L, Goins J, Platten A (2004). Heritable differences in the dopaminergic regulation of sensorimotor gating: II. Temporal, pharmacologic and generational analyses of apomorphine effects on prepulse inhibition. Psychopharmacology 174: 452-462.
35. Swerdlow NR, Stephany N, Shoemaker JM, Ross L, Wasserman LC, Talledo J et al (2002b). Effects of amantadine and bromocriptine on startle and sensorimotor gating: parametric studies and cross species comparisons. Psychopharmacology 164: 82-92.
36. Swerdlow NR, Stephany N, Wasserman LC, Talledo J, Shoemaker JM, Auerbach PP (2003a). Amphetamine effects on prepulse inhibition across species: replication and parametric extension. Neuropsychopharmacology 28: 640-650.
37. Swerdlow NR, Wasserman L, Talledo J, Casas R, Bruins P, Braff DL et al (2003b). Prestimulus modification of the startle reflex: relationship to personality and physiological markers of dopamine function. Biol Psychol 62: 17-26.
38. Swerdlow NR, Zisook D, Taaid N (1994b). Seroquel (ICI 204, 636) restores prepulse inhibition of acoustic startle in apomorphine-treated rats: similarities to clozapine. Psychopharmacology 114: 675-678.
39. Wasserman LC, Stephany NL, Talledo J, Auerbach PP, Swerdlow NR (2002). Psychophysiological effects of quetiapine in normal humans. Program No. 682.2. 2002 Abstract Viewer/Itinerary Planner. Society for Neuroscience: Washington, DC. Online.
40. Weike AI, Bauer U, Hamm AO (2000). Effective neuroleptic medication removes prepulse inhibition deficits in schizophrenia patients. Biol Psychiatry 47: 61-70.
41. Wirshing DA, Spellberg BJ, Erhart SM, Marder SR, Wirshing WC (1998). Novel antipsychotics and new onset diabetes. Biol Psychiatry 44: 778-783.
42. Zuckerman M, Link K (1968). Construct validity for the sensation-seeking scale. J Consult Clin Psychol 32: 420-426.